Literature DB >> 17688255

Proliferative capacity and osteogenic potential of novel dura mater stem cells on poly-lactic-co-glycolic acid.

Caren Petrie1, Sunil Tholpady, Roy Ogle, Edward Botchwey.   

Abstract

The rational design of biomimetic structures for the regeneration of damaged or missing tissue is a fundamental principle of tissue engineering. Multiple variables must be optimized, ranging from the scaffold type to the selection and properties of implanted cell(s). In this study, the osteogenic potential of a novel stem cell was analyzed on biodegradable poly(lactic-co-glycolic acid) (PLGA) biomaterials as a step toward creating new cell-materials constructs for bony regeneration. Dura mater stem cells (DSCs), isolated from rat dura mater, were evaluated and compared to bone marrow stem cells (BMSCs) for proliferative and differentiative properties in vitro. Experiments were carried out on both tissue culture plastic (TCP) and 2D planar films of PLGA. Proliferation of DSCs on both TCP and PLGA films increased over 21 days. Positive fold inductions in all five bone marker genes were observed at days 7, 14, 21 in all experimental samples compared with day 0 controls. DSCs demonstrated greater cell coverage and enhanced matrix staining on 2D PLGA films when compared with BMSCs. These cells can be isolated and expanded in culture and can subsequently attach, proliferate, and differentiate on both TCP and PLGA films to a greater extent than BMSCs. This suggests that DSCs are promising for cell-based bone tissue engineering therapies, particularly those applications involving regeneration of cranial bones. Copyright 2007 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17688255      PMCID: PMC3124866          DOI: 10.1002/jbm.a.31367

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  50 in total

1.  Co-culture of osteoblasts with immature dural cells causes an increased rate and degree of osteoblast differentiation.

Authors:  Jason A Spector; Joshua A Greenwald; Stephen M Warren; Pierre J Bouletreau; Francesca E Crisera; Babak J Mehrara; Michael T Longaker
Journal:  Plast Reconstr Surg       Date:  2002-02       Impact factor: 4.730

2.  Regional differentiation of rat cranial suture-derived dural cells is dependent on association with fusing and patent cranial sutures.

Authors:  B J Mehrara; J Greenwald; G S Chin; M Dudziak; J Sagrioglu; D S Steinbrech; P B Saadeh; G K Gittes; M T Longaker
Journal:  Plast Reconstr Surg       Date:  1999-09       Impact factor: 4.730

3.  Dura mater biology: autocrine and paracrine effects of fibroblast growth factor 2.

Authors:  Jason A Spector; Joshua A Greenwald; Stephen M Warren; Pierre J Bouletreau; Robert C Detch; Peter J Fagenholz; Francesca E Crisera; Michael T Longaker
Journal:  Plast Reconstr Surg       Date:  2002-02       Impact factor: 4.730

4.  Establishment of a rat long-term culture expressing the osteogenic phenotype: dependence on dexamethasone and FGF-2.

Authors:  Shlomo Kotev-Emeth; Sandu Pitaru; Sara Pri-Chen; Naphtali Savion
Journal:  Connect Tissue Res       Date:  2002       Impact factor: 3.417

5.  Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous.

Authors:  A Sen; Y R Lea-Currie; D Sujkowska; D M Franklin; W O Wilkison; Y D Halvorsen; J M Gimble
Journal:  J Cell Biochem       Date:  2001-03-26       Impact factor: 4.429

6.  Proliferation and differentiation of osteoblasts and adipocytes in rat bone marrow stromal cell cultures: effects of dexamethasone and calcitriol.

Authors:  Hassan Atmani; Daniel Chappard; Michel F Basle
Journal:  J Cell Biochem       Date:  2003-05-15       Impact factor: 4.429

7.  Effect of maturation on the osteogenic response of cultured stromal bone marrow cells to basic fibroblast growth factor.

Authors:  S Kotev-Emeth; N Savion; S Pri-chen; S Pitaru
Journal:  Bone       Date:  2000-12       Impact factor: 4.398

Review 8.  Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways.

Authors:  Renny T Franceschi; Guozhi Xiao
Journal:  J Cell Biochem       Date:  2003-02-15       Impact factor: 4.429

9.  Bone formation on two-dimensional poly(DL-lactide-co-glycolide) (PLGA) films and three-dimensional PLGA tissue engineering scaffolds in vitro.

Authors:  Jeffrey M Karp; Molly S Shoichet; John E Davies
Journal:  J Biomed Mater Res A       Date:  2003-02-01       Impact factor: 4.396

10.  Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans.

Authors:  Y H Liu; Z Tang; R K Kundu; L Wu; W Luo; D Zhu; F Sangiorgi; M L Snead; R E Maxson
Journal:  Dev Biol       Date:  1999-01-15       Impact factor: 3.582

View more
  10 in total

1.  FTY720 promotes local microvascular network formation and regeneration of cranial bone defects.

Authors:  Caren E Petrie Aronin; Lauren S Sefcik; Sunil S Tholpady; Ashok Tholpady; Karim W Sadik; Timothy L Macdonald; Shayn M Peirce; Brian R Wamhoff; Kevin R Lynch; Roy C Ogle; Edward A Botchwey
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

2.  3D bioprinter applied picosecond pulsed electric fields for targeted manipulation of proliferation and lineage specific gene expression in neural stem cells.

Authors:  Ross A Petrella; Peter A Mollica; Martina Zamponi; John A Reid; Shu Xiao; Robert D Bruno; Patrick C Sachs
Journal:  J Neural Eng       Date:  2018-05-31       Impact factor: 5.379

3.  Quantitative analysis of immune cell subset infiltration of supraspinatus muscle after severe rotator cuff injury.

Authors:  J R Krieger; L E Tellier; M T Ollukaren; J S Temenoff; E A Botchwey
Journal:  Regen Eng Transl Med       Date:  2017-05-08

4.  Application of PLGA/type I collagen/chitosan artificial composite dura mater in the treatment of dural injury.

Authors:  Wanshan Bai; Xinwei Wang; Wen Yuan; Huixue Wang; Zhanchao Wang
Journal:  J Mater Sci Mater Med       Date:  2013-07-06       Impact factor: 3.896

5.  In vitro and in vivo studies of BMP-2-loaded PCL-gelatin-BCP electrospun scaffolds.

Authors:  Bo-Ram Kim; Thuy Ba Linh Nguyen; Young-Ki Min; Byong-Taek Lee
Journal:  Tissue Eng Part A       Date:  2014-12       Impact factor: 3.845

6.  Comparative effects of scaffold pore size, pore volume, and total void volume on cranial bone healing patterns using microsphere-based scaffolds.

Authors:  Caren E Petrie Aronin; Karim W Sadik; Ann L Lay; Dave B Rion; Sunil S Tholpady; Roy C Ogle; Edward A Botchwey
Journal:  J Biomed Mater Res A       Date:  2009-06       Impact factor: 4.396

7.  Collagen nanofibres are a biomimetic substrate for the serum-free osteogenic differentiation of human adipose stem cells.

Authors:  Lauren S Sefcik; Rebekah A Neal; Stephanie N Kaszuba; Anna M Parker; Adam J Katz; Roy C Ogle; Edward A Botchwey
Journal:  J Tissue Eng Regen Med       Date:  2008-06       Impact factor: 3.963

8.  Osteogenic differentiation of dura mater stem cells cultured in vitro on three-dimensional porous scaffolds of poly(epsilon-caprolactone) fabricated via co-extrusion and gas foaming.

Authors:  C E Petrie Aronin; J A Cooper; L S Sefcik; S S Tholpady; R C Ogle; E A Botchwey
Journal:  Acta Biomater       Date:  2008-03-18       Impact factor: 8.947

9.  Novel Lipid Signaling Mediators for Mesenchymal Stem Cell Mobilization during Bone Repair.

Authors:  Jada M Selma; Anusuya Das; Anthony O Awojoodu; Tiffany Wang; Anjan P Kaushik; Quanjun Cui; Hannah Song; Molly E Ogle; Claire E Olingy; Emily G Pendleton; Kayvan F Tehrani; Luke J Mortensen; Edward A Botchwey
Journal:  Cell Mol Bioeng       Date:  2018-05-29       Impact factor: 2.321

10.  Local delivery of FTY720 induces neutrophil activation through chemokine signaling in an oronasal fistula model.

Authors:  A M Amanso; T C Turner; A Kamalakar; S A Ballestas; L A Hymel; J Randall; R Johnston; R A Arthur; N J Willett; E A Botchwey; S L Goudy
Journal:  Regen Eng Transl Med       Date:  2021-05-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.